These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15753829)

  • 1. Drug treats two sources of cholesterol.
    Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829
    [No Abstract]   [Full Text] [Related]  

  • 2. Ezetimibe combines with simvastatin to tackle cholesterol. New drugs attack "bad" cholesterol in the liver and intestine.
    Heart Advis; 2007 Jul; 10(7):7. PubMed ID: 17695657
    [No Abstract]   [Full Text] [Related]  

  • 3. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inegy: a powerful new medication for lowering LDL cholesterol].
    Rev Med Suisse; 2006 Jun; 2(70):1605. PubMed ID: 16838729
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Davis HR; Murgolo NJ; Graziano MP
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677799
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
    Efrati S; Averbukh M; Dishy V; Faygenzo M; Friedensohn L; Golik A
    Eur J Clin Pharmacol; 2007 Feb; 63(2):113-21. PubMed ID: 17200833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol drug controversy continues.
    Mitka M
    JAMA; 2008 May; 299(19):2266. PubMed ID: 18492963
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption.
    Kvaernø L; Werder M; Hauser H; Carreira EM
    J Med Chem; 2005 Sep; 48(19):6035-53. PubMed ID: 16162006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ezetimibe (Ezetrol) in patients with diabetes].
    Scheen AJ; Radermecker RP
    Rev Med Liege; 2009 Dec; 64(12):606-11. PubMed ID: 20143743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe and other azetidinone cholesterol absorption inhibitors.
    Clader JW
    Curr Top Med Chem; 2005; 5(3):243-56. PubMed ID: 15857308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.
    Meaney A; Ceballos G; Asbun J; Solache G; Mendoza E; Vela A; Meaney E
    J Clin Pharmacol; 2009 Jul; 49(7):838-47. PubMed ID: 19443679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy and clinical trials: ezetimibe.
    Jialal I; Kappagoda T
    Curr Opin Lipidol; 2003 Dec; 14(6):643-6. PubMed ID: 14624143
    [No Abstract]   [Full Text] [Related]  

  • 15. Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139.
    Ahmed MH; Saad RA; Osman MM
    Expert Opin Drug Saf; 2006 Jul; 5(4):487-8. PubMed ID: 16774486
    [No Abstract]   [Full Text] [Related]  

  • 16. Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.
    Gryn SE; Hegele RA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1255-62. PubMed ID: 25920750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.
    Berthold HK; Naini A; Di Mauro S; Hallikainen M; Gylling H; Krone W; Gouni-Berthold I
    Drug Saf; 2006; 29(8):703-12. PubMed ID: 16872244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.